A detailed history of Balyasny Asset Management LLC transactions in Scholar Rock Holding Corp stock. As of the latest transaction made, Balyasny Asset Management LLC holds 408,281 shares of SRRK stock, worth $12.2 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
408,281
Previous 366,078 11.53%
Holding current value
$12.2 Million
Previous $3.05 Million 7.25%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$7.63 - $9.71 $322,008 - $409,791
42,203 Added 11.53%
408,281 $3.27 Million
Q2 2024

Aug 14, 2024

SELL
$7.84 - $16.79 $1.54 Million - $3.29 Million
-196,141 Reduced 34.89%
366,078 $3.05 Million
Q1 2024

May 13, 2024

BUY
$13.2 - $17.76 $7.42 Million - $9.99 Million
562,219 New
562,219 $9.99 Million
Q1 2023

May 15, 2023

SELL
$7.36 - $12.72 $78,575 - $135,798
-10,676 Reduced 42.48%
14,458 $115,000
Q4 2022

Feb 14, 2023

BUY
$7.02 - $9.76 $176,440 - $245,307
25,134 New
25,134 $227,000

Others Institutions Holding SRRK

About Scholar Rock Holding Corp


  • Ticker SRRK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,640,600
  • Market Cap $1.55B
  • Description
  • Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clini...
More about SRRK
Track This Portfolio

Track Balyasny Asset Management LLC Portfolio

Follow Balyasny Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.